| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6159236 | The Journal of Urology | 2012 | 7 Pages |
Abstract
The AR-V1 or V7 transcript level does not predict recurrence in patients with high grade prostate cancer at indeterminate risk for progression. Grade 3 cancer in mixed grade tumors may differ from 100% grade 3 cancer, at least in AR-V1 expression.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Hongjuan Zhao, Marc A. Coram, Rosalie Nolley, Stephen W. Reese, Sarah R. Young, Donna M. Peehl,